Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2026-09-10 20:29:07 ET · period of report 2026-09-09 · accession 0001643653-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-10 20:29 | 2026-09-09 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $43.24 | +3,194 | 66.6K | +5% | +$138.1K |
| DT | 2026-09-10 20:29 | 2026-09-09 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $154.61 | -2,154 | 64.4K | -3% | -$333.0K |
| DT | 2026-09-10 20:29 | 2026-09-09 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $0.00 | -3,194 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-09 | M | A | 3,194 | $43.24 | 66,562 | D | — | — | (F1) Includes an aggregate of 178 shares purchased on February 27, 2026 and August 31, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-09-09 | S | D | 2,154 | $154.61 | 64,408 | D | — | — | (F2) The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. |
| 3 | Derivative | Incentive Stock Option | 2026-09-09 | M | D | 3,194 | $0.00 | 0 | D | $43.24 · — to 2027-02-06 | 3,194 Common Stock | (F3) The option was granted February 6, 2017 and vested in 48 equal monthly installments beginning March 6, 2017. These options were due to expire on February 6, 2027. |